Marty Stempniak

1 week ago | radiologybusiness.com | Marty Stempniak

The U.S. Food and Drug Administration has OK’d the first artificial intelligence tool to predict five-year breast cancer risk from routine mammograms, the product’s developer announced late Friday. The de novo authorization is for Clairity Breast, from the Boston-based vendor with the same name. Most risk assessment models rely on age and genetics, the company noted, but 85% of women diagnosed with the disease do not have a family history.

1 week ago | radiologybusiness.com | Marty Stempniak

The number of radiologists working in private practice continues to plummet, according to new data from the American Medical Association released Thursday. About 46.9% of physicians in the specialty said they work in a setting wholly owned by physicians rather than a hospital, health system or other entity as of last year. That’s down from 49.7% of radiologists in AMA’s previous every-other-year benchmark survey released in 2023 and 63.6% in the inaugural 2012 edition.

1 week ago | radiologybusiness.com | Marty Stempniak

Radiology Partners was the No. 1 initiator of No Surprises Act payment disputes in the second half of 2024 with 136,784, according to new data released Wednesday. The El Segundo, California-based industry giant accounted for about 15% of all disputes in Q4 of 2024 and 18% in Q3. HaloMD, a San Antonio, Texas, firm specializing in NSA dispute resolutions, was No. 2, initiating 134,318, followed by Knoxville, Tennessee, multispecialty group TeamHealth with 94,598.

1 week ago | radiologybusiness.com | Marty Stempniak

Prenuvo on Thursday revealed early findings from its recently launched clinical trial to explore the benefits of elective whole-body MRIs. The Redwood City, California-based radiology group first initiated Project Hercules in June 2024, seeking to enroll 100,000 adults in the study. Led by Chief Radiologist Yosef “Sefi” Chodakiewitz, MD, the trial is expected to last 10 years and is being run out of the Hercules Research Center in Watertown, Massachusetts.

1 week ago | radiologybusiness.com | Marty Stempniak

Bipartisan members of the U.S. Senate recently proposed legislation that would allocate $235 million annually toward bolstering breast and cervical cancer screenings. Sens. Tammy Baldwin, D-Wis., and Susan Collins, R-Maine, have reintroduced the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act.